Trial Profile
Positron Emission Tomography Whole Body Biodistribution Using 18F-AV-45
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2015
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 15 Apr 2015 New trial record